Yamamura A

ORCID: 0000-0001-7564-2102 · 3 papers in corpus
2026
The journal of obstetrics and gynaecology research ·doi:10.1111/jog.70178

AimTo clarify live birth outcomes among women receiving extended or repeated high-dose medroxyprogesterone acetate (MPA) therapy for fertility-sparing management of atypical endometrial hyperplasia or endometrioid carcinoma grade 1.MethodsW…

2025
International cancer conference journal ·doi:10.1007/s13691-024-00739-6

The combination therapy of lenvatinib plus pembrolizumab (LP) is increasingly recognized as an important second-line regimen for advanced or recurrent endometrial cancer (EC). However, the safety and efficacy of conversion surgery with low …

2024
International cancer conference journal ·doi:10.1007/s13691-023-00649-z

Peritoneal tuberculosis (TB) is known to mimic advanced ovarian cancer. In this case report, we describe a unique case of ovarian cancer (endometrioid carcinoma grade 3) at the International Federation of Gynecology and Obstetrics (FIGO) st…